PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27421576-4	2016	Co-administration of L-buthionine-S,R-sulfoximine and MTZ induced acute hepatocellular necrosis and elevated plasma levels of alanine aminotransferase (ALT) from 4h onward in female Balb/c mice.	Methimazole	54-57	glutamic pyruvic transaminase, soluble	Mus musculus	126-150	
27421576-4	2016	Co-administration of L-buthionine-S,R-sulfoximine and MTZ induced acute hepatocellular necrosis and elevated plasma levels of alanine aminotransferase (ALT) from 4h onward in female Balb/c mice.	Methimazole	54-57	glutamic pyruvic transaminase, soluble	Mus musculus	152-155	
24409405-6	2014	RESULTS: Methimazole (100 mg/kg, i.p) administration caused hepatotoxicity as revealed by increase in serum alanine aminotransferase (ALT) activity as well as pathological changes of the liver.	Methimazole	9-20	glutamic pyruvic transaminase, soluble	Mus musculus	108-132	
26839807-9	2015	Methimazole caused liver injury as revealed by increased plasma ALT.	Methimazole	0-11	glutamic pyruvic transaminase, soluble	Mus musculus	64-67	
24409405-6	2014	RESULTS: Methimazole (100 mg/kg, i.p) administration caused hepatotoxicity as revealed by increase in serum alanine aminotransferase (ALT) activity as well as pathological changes of the liver.	Methimazole	9-20	glutamic pyruvic transaminase, soluble	Mus musculus	134-137	
24409405-8	2014	Combined administration of L-buthionine sulfoximine (BSO), as a glutathione depletory agent, caused a dramatic change in methimazole-induced hepatotoxicity characterized by hepatic necrosis and a severe elevation of serum ALT activity.	Methimazole	121-132	glutamic pyruvic transaminase, soluble	Mus musculus	222-225